Basit öğe kaydını göster

Predictive Value of Marker Half-life in Relapsed and Nonrelapsed Nonseminomatous Germ Cell Testicular Tumor Patients Undergoing Chemotherapy

dc.contributor.authorBasaran, Mert
dc.contributor.authorEkenel, MELTEM
dc.contributor.authorKeskin, Serkan
dc.contributor.authorBavbek, Sevil
dc.date.accessioned2021-03-03T14:25:35Z
dc.date.available2021-03-03T14:25:35Z
dc.date.issued2012
dc.identifier.citationKeskin S., Ekenel M., Basaran M., Bavbek S., "Predictive Value of Marker Half-life in Relapsed and Nonrelapsed Nonseminomatous Germ Cell Testicular Tumor Patients Undergoing Chemotherapy", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.35, sa.4, ss.369-372, 2012
dc.identifier.issn0277-3732
dc.identifier.otherav_396f625c-0568-488a-a4eb-e534c0f37b9b
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/42649
dc.identifier.urihttps://doi.org/10.1097/coc.0b013e3182155370
dc.description.abstractBackground: The aim of this study was to investigate the influence of a marker half-life (MHL) on relapse in nonseminomatous germ cell testicular tumor patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titlePredictive Value of Marker Half-life in Relapsed and Nonrelapsed Nonseminomatous Germ Cell Testicular Tumor Patients Undergoing Chemotherapy
dc.typeMakale
dc.relation.journalAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume35
dc.identifier.issue4
dc.identifier.startpage369
dc.identifier.endpage372
dc.contributor.firstauthorID88899


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster